DISCOVID

Serial Number 90030341
Registration 6359994
700

Registration Progress

Application Filed
Jul 1, 2020
Under Examination
Approved for Publication
Mar 9, 2021
Published for Opposition
Mar 9, 2021
Registered
May 25, 2021

Trademark Image

DISCOVID

Basic Information

Serial Number
90030341
Registration Number
6359994
Filing Date
July 1, 2020
Registration Date
May 25, 2021
Published for Opposition
March 9, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 25, 2021
Registration
Registered
Classes
005

Rights Holder

Antagen Biosciences, Inc.

03
Address
650 Albany St., Ste. 112
Boston, MA 02118

Ownership History

Antagen Biosciences, Inc.

Original Applicant
03
Boston, MA

Antagen Biosciences, Inc.

Owner at Publication
03
Boston, MA

Antagen Biosciences, Inc.

Original Registrant
03
Boston, MA

Legal Representation

Attorney
Duan WU

Application History

12 events
Date Code Type Description Documents
May 25, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 9, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 9, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 17, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 29, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 29, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 29, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 29, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 29, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 22, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 29, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 4, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, COVID-19 or coronavirus infection; Diagnostic reagents for medicinal use; Diagnostic biomarker reagents for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Reagents and media for medical and veterinary diagnostic purposes; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents for the analysis of body fluids; all the foregoing goods for detecting and preventing the transmission of the coronavirus
First Use Anywhere: May 31, 2020
First Use in Commerce: May 31, 2020

Classification

International Classes
005